Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Nerve Degeneration D009410 53 associated lipids
Hypertension D006973 115 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Hyperalgesia D006930 42 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Glioblastoma D005909 27 associated lipids
Fabry Disease D000795 4 associated lipids
Influenza, Human D007251 11 associated lipids
Retinal Detachment D012163 10 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Atherosclerosis D050197 85 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Insulin Resistance D007333 99 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Endotoxemia D019446 27 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Acute Lung Injury D055371 33 associated lipids
Sensation Disorders D012678 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Neuralgia D009437 28 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Lung Injury D055370 14 associated lipids
Teratocarcinoma D018243 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Ileus D045823 3 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Cummings RJ et al. Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells. 2002 J. Biol. Chem. pmid:12039947
Cuvillier O Sphingosine in apoptosis signaling. 2002 Biochim. Biophys. Acta pmid:12531549
Osada M et al. Modulation of sphingosine 1-phosphate/EDG signaling by tumor necrosis factor-alpha in vascular endothelial cells. 2002 Thromb. Res. pmid:12590954
Renault AD et al. Metabolism of sphingosine 1-phosphate and lysophosphatidic acid: a genome wide analysis of gene expression in Drosophila. 2002 Gene Expr. Patterns pmid:12617823
Candelore MR et al. Phytosphingosine 1-phosphate: a high affinity ligand for the S1P(4)/Edg-6 receptor. 2002 Biochem. Biophys. Res. Commun. pmid:12270137
Harvey K et al. Serum factors involved in human microvascular endothelial cell morphogenesis. 2002 J. Lab. Clin. Med. pmid:12271276
Katsuma S et al. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. 2002 Genes Cells pmid:12485162
Yun JK and Kester M Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. 2002 Arch. Biochem. Biophys. pmid:12485605
Hirafuji M et al. [Modulation of sphingosine 1-phosphate, a new lipid mediator, on nitric oxide production by vascular smooth muscle cells]. 2002 Nippon Yakurigaku Zasshi pmid:12491784
Muraki K et al. [Effects of sphingosine-1-phosphate, a lipid mediator, in cardiovascular tissues]. 2002 Nippon Yakurigaku Zasshi pmid:12491795
Graeler M and Goetzl EJ Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. 2002 FASEB J. pmid:12468451
Gennero I et al. Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. 2002 J. Biol. Chem. pmid:11821388
Baumruker T and Prieschl EE Sphingolipids and the regulation of the immune response. 2002 Semin. Immunol. pmid:11884231
Kveberg L et al. Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. 2002 Eur. J. Immunol. pmid:12115604
Spiegel S and Kolesnick R Sphingosine 1-phosphate as a therapeutic agent. 2002 Leukemia pmid:12200669
Paris F et al. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. 2002 Nat. Med. pmid:12205432
Davaille J et al. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. 2002 J. Biol. Chem. pmid:12138095
Brailoiu E et al. Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction. 2002 Br. J. Pharmacol. pmid:12163341
Ryu Y et al. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. 2002 Circ. Res. pmid:11861422
Min JK et al. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. 2002 Anal. Biochem. pmid:11950216
Essler M et al. Sphingosine 1-phosphate dynamically regulates myosin light chain phosphatase activity in human endothelial cells. 2002 Cell. Signal. pmid:11955953
Endo A et al. Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. 2002 J. Biol. Chem. pmid:11956190
Bartholomä P et al. Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. 2002 Biochem. Pharmacol. pmid:11996893
Formigli L et al. Sphingosine 1-phosphate induces Ca2+ transients and cytoskeletal rearrangement in C2C12 myoblastic cells. 2002 Am. J. Physiol., Cell Physiol. pmid:11997251
Schilling T et al. Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels. 2002 Neuroscience pmid:11927165
Sano T et al. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. 2002 J. Biol. Chem. pmid:11929870
Spiegel S and Milstien S Sphingosine 1-phosphate, a key cell signaling molecule. 2002 J. Biol. Chem. pmid:12011102
Kihara A and Igarashi Y [Sphingosine 1-phosphate in yeast]. 2002 Tanpakushitsu Kakusan Koso pmid:11915338
Okazaki T and Ito M [Signal transduction of ceramide]. 2002 Tanpakushitsu Kakusan Koso pmid:11915339
Jin ZQ et al. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003800
Igarashi Y [Current studies on a novel lipid mediator, sphingosine 1-phosphate, and its receptors]. 2002 Tanpakushitsu Kakusan Koso pmid:11915345
Black JL and Johnson PR Factors controlling smooth muscle proliferation and airway remodelling. 2002 Curr Opin Allergy Clin Immunol pmid:11964750
Brinkmann V et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. 2002 J. Biol. Chem. pmid:11967257
Liu H et al. Sphingosine kinases: a novel family of lipid kinases. 2002 Prog. Nucleic Acid Res. Mol. Biol. pmid:12102559
Morales M [Participation of the phosphatidylinositol-3-kinase/Akt/endothelial-nitric-oxide synthase signaling in the processes of angiogenesis and vascular remodeling]. 2002 Nefrologia pmid:12107910
Karliner JS Lysophospholipids and the cardiovascular system. 2002 Biochim. Biophys. Acta pmid:12069831
English D et al. Lipid mediators of angiogenesis and the signalling pathways they initiate. 2002 Biochim. Biophys. Acta pmid:12069833
Spiegel S et al. Sphingosine 1-phosphate signaling: providing cells with a sense of direction. 2002 Trends Cell Biol. pmid:12062172
Kohno T et al. N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization. 2002 FASEB J. pmid:12087059
Mallick S et al. Human placental lipid induces mitogenesis and melanogenesis in B16F10 melanoma cells. 2002 J. Biosci. pmid:12089473
Vouret-Craviari V et al. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. 2002 J. Cell. Sci. pmid:12045218
Kozawa O et al. Sphingomyelinase amplifies BMP-4-induced osteocalcin synthesis in osteoblasts: role of ceramide. 2002 Cell. Signal. pmid:12359305
Koide Y et al. Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships. 2002 J. Med. Chem. pmid:12361389
Tamama K and Okajima F Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology. 2002 Curr. Opin. Lipidol. pmid:12352012
Jolly PS et al. The roles of sphingosine-1-phosphate in asthma. 2002 Mol. Immunol. pmid:12217390
Niedernberg A et al. Comparative analysis of human and rat S1P(5) (edg8): differential expression profiles and sensitivities to antagonists. 2002 Biochem. Pharmacol. pmid:12234605
Payne SG et al. Sphingosine-1-phosphate: dual messenger functions. 2002 FEBS Lett. pmid:12401202
Lampasso JD et al. Role of protein kinase C alpha in primary human osteoblast proliferation. 2002 J. Bone Miner. Res. pmid:12412804
Napier JA et al. A new class of lipid desaturase central to sphingolipid biosynthesis and signalling. 2002 Trends Plant Sci. pmid:12417141
Uhlenbrock K et al. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. 2002 Cell. Signal. pmid:12220620